Yamashita, Kazuto
Miura, Masahiro
Watanabe, Shunsuke
Ishiki, Kengo
Arimatsu, Yuji
Kawahira, Junko
Kubo, Toshiko
Sasaki, Katsutaka
Arai, Takayuki
Hagino, Kei
Irino, Yasuhiro
Nagai, Kota
Verbel, David
Koyama, Akihiko
Dhadda, Shobha
Niiro, Hayato
Iwanaga, Shigeki
Sato, Toshiyuki
Yoshida, Tomokazu
Iwata, Atsushi
Article History
Received: 30 March 2022
Accepted: 15 June 2022
First Online: 23 June 2022
Declarations
:
: All studies were conducted in accordance with the Declaration of Helsinki and after approval of the local ethics committees of the participating centers. All participants (or their legal representatives) provided written informed consent prior to enrolling in MissionAD.
: Not applicable.
: KY, MM, SW, KI, YA, JK, KS, TA, KH, YI, HN, SI, and TS were employees of Sysmex Corporation. TK is an employee of Sysmex R&D Center Americas Inc. KN is an employee of Eisai Co. Ltd. DV, AK, and SD are employees of Eisai, Inc. TY is a board member of Sysmex Corporation. AI received lectures and advisory fees from Eisai, Daiichi Sankyo, MSD, Biogen, Janssen, and Sysmex. AI has received research grants from Eisai, Daiichi Sankyo, MSD, Shionogi, Kyowa Kirin, and Abbvie.